Global Antidiabetics Market Research Report 2023(Status and Outlook)


Attention: There is an updated edition available for this report.

Global Antidiabetics Market Research Report 2023(Status and Outlook)



Report Overview

Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.

The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share.

Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.

The Global Antidiabetics Market Size was estimated at USD 58180.00 million in 2022 and is projected to reach USD 85762.74 million by 2029, exhibiting a CAGR of 5.70% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Antidiabetics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antidiabetics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antidiabetics market in any manner.

Global Antidiabetics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sanofi-Aventis

Takeda Pharmaceuticals

Eli Lilly

Oramed Pharmaceuticals

Boehringer Ingelheim

Merck & Co. Inc.

Novo Nordisk

Bristol-Myers Squibb

Halozyme Therapeutics

Pfizer

Market Segmentation (by Type)

Type 1 Diabetes

Type 2 Diabetes

Other

Market Segmentation (by Application)

Cruise and Ferry

Offshore Vessel

Merchant

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Antidiabetics Market

Overview of the regional outlook of the Antidiabetics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antidiabetics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Antidiabetics
1.2 Key Market Segments
1.2.1 Antidiabetics Segment by Type
1.2.2 Antidiabetics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antidiabetics Market Overview
2.1 Global Market Overview
2.1.1 Global Antidiabetics Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Antidiabetics Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Antidiabetics Market Competitive Landscape
3.1 Global Antidiabetics Sales by Manufacturers (2018-2023)
3.2 Global Antidiabetics Revenue Market Share by Manufacturers (2018-2023)
3.3 Antidiabetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antidiabetics Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Antidiabetics Sales Sites, Area Served, Product Type
3.6 Antidiabetics Market Competitive Situation and Trends
3.6.1 Antidiabetics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antidiabetics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Antidiabetics Industry Chain Analysis
4.1 Antidiabetics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Antidiabetics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Antidiabetics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antidiabetics Sales Market Share by Type (2018-2023)
6.3 Global Antidiabetics Market Size Market Share by Type (2018-2023)
6.4 Global Antidiabetics Price by Type (2018-2023)
7 Antidiabetics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antidiabetics Market Sales by Application (2018-2023)
7.3 Global Antidiabetics Market Size (M USD) by Application (2018-2023)
7.4 Global Antidiabetics Sales Growth Rate by Application (2018-2023)
8 Antidiabetics Market Segmentation by Region
8.1 Global Antidiabetics Sales by Region
8.1.1 Global Antidiabetics Sales by Region
8.1.2 Global Antidiabetics Sales Market Share by Region
8.2 North America
8.2.1 North America Antidiabetics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antidiabetics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antidiabetics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antidiabetics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antidiabetics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Sanofi-Aventis
9.1.1 Sanofi-Aventis Antidiabetics Basic Information
9.1.2 Sanofi-Aventis Antidiabetics Product Overview
9.1.3 Sanofi-Aventis Antidiabetics Product Market Performance
9.1.4 Sanofi-Aventis Business Overview
9.1.5 Sanofi-Aventis Antidiabetics SWOT Analysis
9.1.6 Sanofi-Aventis Recent Developments
9.2 Takeda Pharmaceuticals
9.2.1 Takeda Pharmaceuticals Antidiabetics Basic Information
9.2.2 Takeda Pharmaceuticals Antidiabetics Product Overview
9.2.3 Takeda Pharmaceuticals Antidiabetics Product Market Performance
9.2.4 Takeda Pharmaceuticals Business Overview
9.2.5 Takeda Pharmaceuticals Antidiabetics SWOT Analysis
9.2.6 Takeda Pharmaceuticals Recent Developments
9.3 Eli Lilly
9.3.1 Eli Lilly Antidiabetics Basic Information
9.3.2 Eli Lilly Antidiabetics Product Overview
9.3.3 Eli Lilly Antidiabetics Product Market Performance
9.3.4 Eli Lilly Business Overview
9.3.5 Eli Lilly Antidiabetics SWOT Analysis
9.3.6 Eli Lilly Recent Developments
9.4 Oramed Pharmaceuticals
9.4.1 Oramed Pharmaceuticals Antidiabetics Basic Information
9.4.2 Oramed Pharmaceuticals Antidiabetics Product Overview
9.4.3 Oramed Pharmaceuticals Antidiabetics Product Market Performance
9.4.4 Oramed Pharmaceuticals Business Overview
9.4.5 Oramed Pharmaceuticals Antidiabetics SWOT Analysis
9.4.6 Oramed Pharmaceuticals Recent Developments
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Antidiabetics Basic Information
9.5.2 Boehringer Ingelheim Antidiabetics Product Overview
9.5.3 Boehringer Ingelheim Antidiabetics Product Market Performance
9.5.4 Boehringer Ingelheim Business Overview
9.5.5 Boehringer Ingelheim Antidiabetics SWOT Analysis
9.5.6 Boehringer Ingelheim Recent Developments
9.6 Merck andamp; Co. Inc.
9.6.1 Merck andamp; Co. Inc. Antidiabetics Basic Information
9.6.2 Merck andamp; Co. Inc. Antidiabetics Product Overview
9.6.3 Merck andamp; Co. Inc. Antidiabetics Product Market Performance
9.6.4 Merck andamp; Co. Inc. Business Overview
9.6.5 Merck andamp; Co. Inc. Recent Developments
9.7 Novo Nordisk
9.7.1 Novo Nordisk Antidiabetics Basic Information
9.7.2 Novo Nordisk Antidiabetics Product Overview
9.7.3 Novo Nordisk Antidiabetics Product Market Performance
9.7.4 Novo Nordisk Business Overview
9.7.5 Novo Nordisk Recent Developments
9.8 Bristol-Myers Squibb
9.8.1 Bristol-Myers Squibb Antidiabetics Basic Information
9.8.2 Bristol-Myers Squibb Antidiabetics Product Overview
9.8.3 Bristol-Myers Squibb Antidiabetics Product Market Performance
9.8.4 Bristol-Myers Squibb Business Overview
9.8.5 Bristol-Myers Squibb Recent Developments
9.9 Halozyme Therapeutics
9.9.1 Halozyme Therapeutics Antidiabetics Basic Information
9.9.2 Halozyme Therapeutics Antidiabetics Product Overview
9.9.3 Halozyme Therapeutics Antidiabetics Product Market Performance
9.9.4 Halozyme Therapeutics Business Overview
9.9.5 Halozyme Therapeutics Recent Developments
9.10 Pfizer
9.10.1 Pfizer Antidiabetics Basic Information
9.10.2 Pfizer Antidiabetics Product Overview
9.10.3 Pfizer Antidiabetics Product Market Performance
9.10.4 Pfizer Business Overview
9.10.5 Pfizer Recent Developments
10 Antidiabetics Market Forecast by Region
10.1 Global Antidiabetics Market Size Forecast
10.2 Global Antidiabetics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antidiabetics Market Size Forecast by Country
10.2.3 Asia Pacific Antidiabetics Market Size Forecast by Region
10.2.4 South America Antidiabetics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antidiabetics by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Antidiabetics Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Antidiabetics by Type (2024-2029)
11.1.2 Global Antidiabetics Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Antidiabetics by Type (2024-2029)
11.2 Global Antidiabetics Market Forecast by Application (2024-2029)
11.2.1 Global Antidiabetics Sales (K MT) Forecast by Application
11.2.2 Global Antidiabetics Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings